0
Generation Bio Co. Banner Image

Generation Bio Co.

  • Ticker GBIO
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Generation Bio Co. Logo Image
  • 51-200 Employees
  • Based in Cambridge, Massachusetts
Generation Bio is innovating genetic medicines to provide durable, redosable treatments for people living with rare and prevalent diseases. The company’s non-viral genetic medicine platform incorporates a novel DNA construct called closed-ended DNA, or ceDNA; a unique cell-targeted lipid nanoparticle delivery system, or ctLNP; and a highly scalable capsid-free manufacturing process thatMore uses proprietary cell-free rapid enzymatic synthesis, or RES, to produce ceDNA. The platform is designed to enable multi-year durability from a single dose, to deliver large genetic payloads, including multiple genes, to specific tissues and cell types, and to allow titration and redosing to adjust or extend expression levels in each patient. RES has the potential to expand Generation Bio’s manufacturing scale to hundreds of millions of doses to support its mission to extend the reach of genetic medicine to more people, living with more diseases, around the world.
Generation Bio Co.

Most Recent Annual Report

Generation Bio Co.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Generation Bio Co. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!